B-Cell Depletion Therapy Market

Future Market Insights

Key Insight

The B-cell depletion therapy market is projected to grow from USD 26.7 billion in 2026 to USD 62.6 billion by 2036, at a CAGR of 8.9%. Anti-CD20 mAbs will dominate with a 70.0% market share, while autoimmune diseases will lead the application segment with a 60.0% share.

December 23, 2025

Anurag Sharma

250 Pages

Cite this Report

B-Cell Depletion Therapy Market

https://www.futuremarketinsights.com/reports/b-cell-depletion-therapy-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

Biogen Inc
GSK plc
The Vanguard Group
Novartis
Roche

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

B-Cell Depletion Therapy Market

Key Players

Similar Industry Reports